Cite
HARVARD Citation
Batenchuk, C. et al. (2018). A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies. Journal of clinical pathology. 71 (12), pp. 1078-1083. [Online].